News
Yecuris offers MetAbArrayâ„¢ In-Cell Proteomics Screening

17-Mar-2014.

Yecurisexclusively licenses the rights to offer the novel in-cell proteomics method known as the MetAbArray™ for in vitro and in vivo compound screening for toxicity and metabolism assessment.  This unique platform allows rapid scoring of compounds through the measurement of ten physiological pathways that provide a whole cell panorama allowing elucidation of specific proteins of interest.  The offering will be detailed at the 2014 SOT where the method is featured in several poster sessions.